Zura Bio ZURA Institutional Ownership

Updated Oct 11, 2026

Zura Bio Ltd (NASDAQ:ZURA) counted 96 institutional investors among its 13F-reported shareholders for the quarter ended June 30, 2026.

• Their combined stake equaled 57.52% of outstanding shares in Q2 2026, down from 58.61% in Q1 2026.
• Total shares held in Zura Bio rose 10.89% versus Q1 2026, while the number of holders rose 52.38% versus Q2 2025.
• Among the 96 holders of Zura Bio, 61 added to their positions, 18 reduced their stakes and 17 left their positions unchanged.
• In total, institutional investors held 72.94Mn shares of Zura Bio at the end of Q2 2026, up 7.16Mn from the prior quarter and up 37.84Mn from a year earlier.
• Montanova Capital, LLC led 13F holders of ZURA with 9.44Mn shares as of June 30, 2026, or 7.45% of shares outstanding.
• Holders that added the most shares of Zura Bio in Q2 2026 were BlackRock, Inc. (+3.16Mn shares), Saturn V Capital Management LP (+1.36Mn shares), ADAR1 Capital Management, LLC (+1.13Mn shares), Geode Capital Management, LLC (+1.06Mn shares) and State Street Corp (+806.67K shares).
• On the other side, among holders that kept a position in Zura Bio, the largest reductions in Q2 2026 came from Pfizer Inc (-2.3Mn shares), Millennium Management LLC (-1.37Mn shares), Affinity Asset Advisors, LLC (-1.1Mn shares), Morgan Stanley (-367K shares) and JPMorgan Chase & Co (-104.14K shares).
• Zura Bio's 10 largest institutional shareholders as of Q2 2026 were Montanova Capital, LLC (9.44Mn shares), Venrock Adviser, LLC (6.43Mn shares), MPM BioImpact LLC (4.47Mn shares), JPMorgan Chase & Co (4.35Mn shares), Great Point Partners LLC (4.22Mn shares), Braidwell LP (3.98Mn shares), Siren, L.L.C. (3.73Mn shares), BlackRock, Inc. (3.61Mn shares), Commodore Capital LP (3.25Mn shares) and Adage Capital Partners GP, L.L.C. (2.75Mn shares), per Business Quant data.